KeyCorp Estimates Stevanato Group FY2027 Earnings

Stevanato Group S.p.A. (NYSE:STVN – Free Report) – Stock analysts at KeyCorp issued their FY2027 earnings per share (EPS) estimates for shares of Stevanato Group in a research note issued on Tuesday, November 3rd. KeyCorp analyst P. Knight expects that the company will post earnings per share of $0.70 for the year. The consensus estimate for Stevanato Group’s current full-year earnings is $0.67 per share.

Stevanato Group (NYSE:STVN – Get Free Report) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported €0.16 earnings per share for the quarter, missing the consensus estimate of €0.17 by (€0.01). The firm had revenue of €326.06 million for the quarter. Stevanato Group had a return on equity of 10.51% and a net margin of 11.24%.

A number of other research firms also recently issued reports on STVN. William Blair downgraded shares of Stevanato Group from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 4th. Weiss Ratings raised shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. Deutsche Bank assumed coverage on shares of Stevanato Group in a research report on Wednesday, October 7th. They issued a “hold” rating for the company. UBS Group lowered their price target on shares of Stevanato Group from $23.00 to $16.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 4th. Finally, Citigroup cut their price target on shares of Stevanato Group from $26.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, November 4th. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Get Our Latest Stock Analysis on Stevanato Group

Stevanato Group Stock Up 9.8%

NYSE STVN traded up €1.41 during trading on Friday, hitting €15.77. The stock had a trading volume of 1,458,000 shares, compared to its average volume of 567,558. The company has a market capitalization of $4.78 billion, a PE ratio of 27.19, a P/E/G ratio of 1.49 and a beta of 0.80. The company’s 50-day moving average price is €19.14 and its two-hundred day moving average price is €17.91. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.19 and a current ratio of 1.73. Stevanato Group has a 12 month low of €12.05 and a 12 month high of €24.01.

Institutional Investors Weigh In On Stevanato Group

Several hedge funds have recently bought and sold shares of STVN. First Bank & Trust raised its stake in shares of Stevanato Group by 3.4% during the second quarter. First Bank & Trust now owns 18,417 shares of the company’s stock valued at $333,000 after acquiring an additional 603 shares during the last quarter. Fifth Third Bancorp grew its stake in shares of Stevanato Group by 22.6% in the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after purchasing an additional 773 shares during the last quarter. PineStone Asset Management Inc. increased its holdings in Stevanato Group by 8.4% in the third quarter. PineStone Asset Management Inc. now owns 41,335 shares of the company’s stock valued at $867,000 after purchasing an additional 3,200 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in Stevanato Group in the second quarter valued at $59,000. Finally, GW&K Investment Management LLC raised its position in Stevanato Group by 118.3% during the 3rd quarter. GW&K Investment Management LLC now owns 6,086 shares of the company’s stock worth $128,000 after purchasing an additional 3,298 shares during the last quarter.

Insiders Place Their Bets

In other news, Director E Jr purchased 25,000 shares of the company’s stock in a transaction on Friday, November 6th. The shares were purchased at an average cost of €13.07 per share, with a total value of €326,750.00. Following the completion of the transaction, the director owned 62,424 shares of the company’s stock, valued at €815,881.68. The trade was a 66.80% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mauro Stocchi sold 13,649 shares of the stock in a transaction on Monday, September 28th. The shares were sold at an average price of €21.50, for a total transaction of €293,453.50. Following the completion of the sale, the insider owned 400,000 shares of the company’s stock, valued at approximately €8,600,000. This represents a 3.30% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.70% of the company’s stock.

About Stevanato Group

(Get Free Report)

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

Featured Articles

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.